MediWound (MDWD) News
NASDAQ: MDWDHealth Care Medicinal Chemicals and Botanical Products USD
13.59+0.05 (+0.37%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MDWD news summary
We found 5 recent headlines mentioning MediWound (MDWD): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, MDWD is up 0.37% at $13.59. The most recent story, "MediWound (MDWD) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest MediWound headlines
- MediWound (MDWD) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaqMDWD, BRK.B
- MediWound Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateEscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027GlobeNewswire
- MediWound Ltd. Enters Underwriting Agreement for $17.25 million Public OfferingOn November 3, 2026, MediWound Ltd. entered into an underwriting agreement with H.C. Wainwright & Co., LLC relating to the public offering of 1,200,000 ordinary shares, par value NIS 0.07 per share,…Nasdaq
- MediWound Announces $15 Million Bought Deal Offering of Ordinary SharesMediWound Announces $15 Million Bought Deal Offering of Ordinary SharesGlobeNewswire
- Madrigal (MDGL) Q3 Earnings and Revenues Beat EstimatesMadrigal (MDGL) delivered earnings and revenue surprises of +267.89% and +7.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqMDGL, MDWD